Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer-Reference-Cited by-同舟云学术

Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer

Published:2021-11 Issue:11 Volume:23 Page:2105-2113
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Hamilton Jada G.,Symecko Heather,Spielman Kelsey,Breen Kelsey,Mueller Rebecca,Catchings Amanda,Trottier Magan,Salo-Mullen Erin E.,Shah Ibrahim,Arutyunova Anna,Batson Melissa,Gebert Rebecca,Pundock Stacy,Schofield Elizabeth,Offit Kenneth,Stadler Zsofia K.,Cadoo Karen,Carlo Maria I.,Narayan Vivek,Reiss Kim A.,Robson Mark E.,Domchek Susan M.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

https://www.nature.com/articles/s41436-021-01262-2.pdf

Reference40 articles.

1. The DNA damaging revolution: PARP inhibitors and beyond;Yap;Am Soc Clin Oncol Educ Book,2019

2. Next-generation service delivery: A scoping review of patient outcomes associated with alternative models of genetic counseling and genetic testing for hereditary cancer;McCuaig;Cancers (Basel),2018

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Familial Cancers;International Encyclopedia of Public Health;2025

2. Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models;JAMA Network Open;2024-09-09

3. Universal screening of colorectal tumors for lynch syndrome: a survey of patient experiences and opinions;Hereditary Cancer in Clinical Practice;2024-09-05

4. Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer;JAMA Network Open;2024-09-03

5. Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma;JCO Oncology Practice;2024-08